HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rosenberg, L Search for Related Content PubMed PubMed Citation Articles by Rosenberg, L

Hormone replacement therapy: the need for reconsideration.

L Rosenberg

Slone Epidemiology Unit, Boston University School of Medicine, Brookline, MA 02146.

Millions of menopausal women are taking hormone supplements. Observational studies suggest that unopposed estrogens reduce the risk of cardiovascular disease and fractures and increase the risk of endometrial cancer and, possibly, breast cancer. In the absence of information from randomized trials, how much of the apparent beneficial effect on heart disease is due to the tendency of healthier women to use these drugs is unknown. The effect on the cardiovascular system of estrogen taken with a progestin is unknown, and this regimen may increase the risk of breast cancer. An approach to health and illness that focuses on a single cause or preventive and on single organ systems is severely limited. Alternative ways to improve cardiovascular and skeletal health that do not increase the risk of cancer are available. A reconsideration of the appropriate use of hormone supplements is needed.

This article has been cited by other articles:

				N. Krieger Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections Int. J. Epidemiol., June 1, 2008; 37(3): 627 - 637. [Abstract] [Full Text] [PDF]

				C. Paul Commentary: Hormone therapy and breast cancer incidence: did epidemiologists miss an effect on national trends? Int. J. Epidemiol., June 1, 2008; 37(3): 638 - 640. [Full Text] [PDF]

				N. Krieger, I. Lowy, R. Aronowitz, J. Bigby, K. Dickersin, E. Garner, J.-P. Gaudilliere, C. Hinestrosa, R. Hubbard, P. A Johnson, et al. Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives J. Epidemiol. Community Health, September 1, 2005; 59(9): 740 - 748. [Abstract] [Full Text] [PDF]

				N. Krieger Embodiment: a conceptual glossary for epidemiology J. Epidemiol. Community Health, May 1, 2005; 59(5): 350 - 355. [Abstract] [Full Text] [PDF]

				K. K. Koh and I. Sakuma Should Progestins Be Blamed for the Failure of Hormone Replacement Therapy to Reduce Cardiovascular Events in Randomized Controlled Trials? Arterioscler. Thromb. Vasc. Biol., July 1, 2004; 24(7): 1171 - 1179. [Abstract] [Full Text] [PDF]

				C. Rodriguez, E. E. Calle, A. V. Patel, L. M. Tatham, E. J. Jacobs, and M. J. Thun Effect of Body Mass on the Association between Estrogen Replacement Therapy and Mortality among Elderly US Women Am. J. Epidemiol., January 15, 2001; 153(2): 145 - 152. [Abstract] [Full Text] [PDF]

				T. W. Abel, M. L. Voytko, and N. E. Rance The Effects of Hormone Replacement Therapy on Hypothalamic Neuropeptide Gene Expression in a Primate Model of Menopause J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2111 - 2118. [Abstract] [Full Text]

				M Stampfer, F Grodstein, D Spiers, W F M Posthuma, R G J Westendorp, and J P Vandenbroucke Cardioprotective effect of hormone replacement therapy Is not due to a selection bias BMJ, September 24, 1994; 309(6957): 808b - 809. [Full Text]